Myocarditis
·MeSH: Myocarditis
Prevalence
5.0 / 100K
Incidence
13.4 / 100K/yr
6 drugs in development·6 companies·1 clinical trial
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| CardiolRx | Cardiol Therapeutics Inc. (CRDL) |
Phase 1(1)
| Drug | Company |
|---|---|
| mRNA-1273 | Moderna, Inc. (MRNA) |
Compare drugs
Frequently asked questions
How many drugs are in development for Myocarditis?
BioSniper tracks 6 drugs in development for Myocarditis across 6 companies.
How many clinical trials target Myocarditis?
There are 1 clinical trial targeting Myocarditis tracked by BioSniper.
What is the prevalence of Myocarditis?
The estimated prevalence of Myocarditis is approximately 5.0 per 100,000 population.
Deep-dive into Myocarditis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis